Experimental studies suggest that
carotenoids and
retinol may play a role in
carcinogenesis, but epidemiological evidence is lacking. We investigated the prospective associations between plasma concentrations of major
carotenoids and
retinol, and overall and
breast cancer risk. A nested case-control study included all first incident
cancer cases diagnosed in the SU.VI.MAX cohort between 1994 and 2002 (n = 159 cases, 1 matched control/case). Baseline plasma concentrations of
carotenoids and
retinol were measured by high-performance liquid chromatography. Conditional logistic regression was used to assess odds ratios for an increase of 0.1 μmol/L [odds ratio (OR)] and 95% confidence intervals (CI). Plasma β-
carotene (OR = 0.95, 95% CI = 0.90-0.99, Ptrend = 0.04) and β-
cryptoxanthin concentrations (OR = 0.89, 95% CI = 0.81-0.99, Ptrend = 0.03) were inversely associated with overall
cancer risk. Plasma β-
cryptoxanthin concentration was inversely associated with
breast cancer risk (OR = 0.83, 95% CI = 0.71-0.96, Ptrend = 0.02). The OR between plasma
lycopene concentration and overall
cancer risk was 1.07 (0.99-1.15), Ptrend = 0.06. This association turned significant (Ptrend = 0.01) when excluding
cancer cases diagnosed during the first year of follow-up. This prospective study suggests an inverse association between plasma concentrations of β-
cryptoxanthin and both overall and
breast cancer risk, and an inverse association between β-
carotene and overall
cancer risk. The direct association between
lycopene concentration and
cancer risk deserves further investigation.